Faculty Opinions recommendation of Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia.

2019 ◽  
Author(s):  
Jan Starý ◽  
Barbora Vakrmanova
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
T Cell ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Lymphoblastic Leukemia ◽  
Preclinical Model ◽  
Cell Acute Lymphoblastic Leukemia ◽  
Minimal Residual

scholarly journals Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia

Blood ◽  
2019 ◽  
Vol 134 (8) ◽  
pp. 713-716 ◽  
Author(s):  
Fotini Vogiatzi ◽  
Dorothee Winterberg ◽  
Lennart Lenk ◽  
Swantje Buchmann ◽  
Gunnar Cario ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
T Cell ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Lymphoblastic Leukemia ◽  
Preclinical Model ◽  
Cell Acute Lymphoblastic Leukemia ◽  
Minimal Residual

scholarly journals DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T‐Cell Acute Lymphoblastic Leukemia

2016 ◽  
Vol 63 (7) ◽  
pp. 1185-1192 ◽  
Author(s):  
Magnus Borssén ◽  
Zahra Haider ◽  
Mattias Landfors ◽  
Ulrika Norén‐Nyström ◽  
Kjeld Schmiegelow ◽  
...  
Keyword(s):  
Dna Methylation ◽  
Acute Lymphoblastic Leukemia ◽  
T Cell ◽  
Minimal Residual Disease ◽  
Prognostic Value ◽  
Residual Disease ◽  
Lymphoblastic Leukemia ◽  
Disease Status ◽  
Cell Acute Lymphoblastic Leukemia ◽  
Minimal Residual
Sign in / Sign up

Export Citation Format

Share Document